Carbon Revolution plc (Nasdaq: CREV) (the “Company”), a Tier 1 OEM supplier and the leading global manufacturer of lightweight advanced technology automotive carbon fiber wheels, today announced that ...

Strategy, formerly known as MicroStrategy, has successfully completed a massive capital raise, securing $2.5 billion through preferred stock issuance - five times the originally planned $500 million.

HCA Healthcare has delivered impressive second-quarter results that exceeded analyst expectations, with revenue climbing 6.4% to $18.61 billion, surpassing the projected $18.50 billion. The company's ...

Lassonde Industries Inc. (TSX: LAS.A) ("Lassonde" or the "Corporation") is pleased to announce that it will host a conference call to discuss its financial results for the second quarter of 2025 on ...

Sagtec Global Limited (NASDAQ: SAGT) (“Sagtec” or the “Company”), a provider of enterprise software solutions for high-growth verticals, today announced the successful delivery of the first phase of ...

CSX Corporation has become a focal point of merger speculation as industry consolidation gains momentum in the U.S. railroad sector. The company's stock is attracting investor attention following ...

In recent years, the gold market has entered a strong upward cycle, with both technical and fundamental factors driving prices higher. By mid-July 2025, various technical indicators have shown ...

Fresh Puma information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Fresh Vallourec information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- Imperial Metals Corporation (“Imperial” or the “Company”) (TSX:III) provides an update on the two fall of ground incidents at the 30% ...

SIMPPLE Ltd. (NASDAQ: SPPL) (“SIMPPLE” or “the Company”), a leading technology provider and innovator in the facilities management (FM) sector, today announced that it has received notice from The ...

The European Commission has granted approval for Bayer's cancer medication Nubeqa to be used in treating metastatic hormone-sensitive prostate cancer, marking a significant milestone for the ...